Meliolabs
Latest round
- Seed
Last raised
- Aug 2022
Total raised
- Undisclosed
Investors
- 1
About Meliolabs
, operates as a developer of artificial intelligence-powered sequence profiling platform to identify blood-based pathogens using a novel DNA melting technique. In January 2025, Meliolabs Inc. The company offers an artificial intelligence-based instrument platform that identifies blood-based pathogens. The devices use novel DNA melting techniques to provide end-to-end integrated user workflow serving medical and diagnostic laboratories.
Who invested in Meliolabs
1 investor across 1 round
See all investors in Meliolabs
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Aug 26, 2022
Amount
Undisclosed
Investors
Questions about Meliolabs
Who invested in Meliolabs?
Meliolabs has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Meliolabs raised?
Meliolabs has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Meliolabs last raise money?
Meliolabs's most recent round on record is a Seed, in Aug 2022.
What does Meliolabs do?
, operates as a developer of artificial intelligence-powered sequence profiling platform to identify blood-based pathogens using a novel DNA melting technique.
Where is Meliolabs headquartered?
Meliolabs is headquartered in Santa Clara, US.
Which VCs invest in companies like Meliolabs?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Meliolabs's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Seed
Raising like Meliolabs? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.